Urolithiasis Management Devices Market: Market Size & Forecast 2026

The urolithiasis management devices market covers a broad range of clinical tools used to diagnose, fragment, and remove urinary tract stones, spanning diagnostic imaging equipment, flexible and semi-rigid ureteroscopes, intracorporeal lithotripters, and associated accessories. The global market reached approximately $1.82 billion in 2025 and is expected to expand at a steady compound annual growth rate, reflecting sustained clinical demand coupled with ongoing technological innovation in minimally invasive stone management.

• •Minimally invasive procedures such as ureteroscopy and laser lithotripsy have largely replaced open surgery as the standard of care
• •Recurrence rates of kidney stones are notably high, with studies documenting rising incidence in both developed and developing nations
• •Economic burden studies estimate billions of dollars in global healthcare costs attributable to urolithiasis by 2030

Epidemiological trends reveal a significant and sustained increase in urolithiasis incidence globally, with documented rises in both the United States and China over recent decades, directly expanding the patient population requiring intervention. A growing body of clinical and economic literature highlights a rising disease burden among working-age adults, amplifying pressure on healthcare systems to provide cost-effective therapeutic options. Furthermore, recurrent stone formation means patients often require multiple procedures over their lifetime, sustaining long-term demand for management devices.

• •Rising global prevalence driven by metabolic syndrome, obesity, diabetes, and dietary risk factors such as high sodium and low fluid intake
• •High recurrence rates, estimated at approximately 50% within five to ten years, create sustained repeat-procedure demand
• •Increasing adoption of disposable flexible ureteroscopes, driven by infection control concerns and favorable cost-effectiveness analyses in hospital settings

The market is commonly segmented by product type, including ureteroscopes, lithotripters, stone retrieval devices, laser systems, and accessories, as well as by end user (hospitals, ambulatory surgical centers, and specialty clinics). Geographically, North America currently represents the largest market due to high disease prevalence, advanced healthcare infrastructure, and widespread reimbursement for minimally invasive procedures, while the Asia-Pacific region is expected to register the fastest growth as awareness, diagnostic capacity, and healthcare spending rise.

• •Product segments range from reusable semi-rigid ureteroscopes to single-use flexible ureteroscopes and extracorporeal shock wave lithotripters
• •North America leads in market share, supported by high stone prevalence and established minimally invasive treatment pathways
• •Asia-Pacific and emerging markets are expanding rapidly due to growing urology care access, urbanization, and shifting dietary patterns

What are the recent trends and outlook?

The industry is experiencing a measurable shift toward single-use flexible ureteroscopes, as clinical evidence supports reduced infection transmission risk and favorable cost profiles despite higher per-unit device costs. Ongoing technological advances in laser lithotripsy, improved miniature imaging sensors, and AI-assisted stone characterization are expected to further differentiate product offerings. Looking ahead, the combination of a growing and aging patient base, rising global stone prevalence, and continued procedural volume growth positions the urolithiasis management devices market for sustained expansion through the end of the decade and beyond.

• •Single-use flexible ureteroscopes are gaining traction as hospitals balance infection control priorities against procedural cost structures
• •Integration of smaller diameter optics and enhanced laser platforms is driving higher procedural efficiency and improved patient outcomes
• •Continued growth is underpinned by the interplay of rising disease prevalence, aging demographics, and persistent demand for repeat interventions